Brent Saun­ders to lead Bausch + Lomb in re­turn to CEO slot

Three years af­ter com­plet­ing Al­ler­gan’s $63 bil­lion sale to Ab­b­Vie and walk­ing away with a near­ly $39 mil­lion gold­en para­chute, Brent Saun­ders is back to lead a pub­lic com­pa­ny once again.

Saun­ders, a pro­lif­ic deal­mak­er and a tow­er­ing fig­ure in biotech, has been ap­point­ed the CEO and chair­man at Bausch + Lomb, suc­ceed­ing Joseph Pa­pa.

It would be Saun­ders’ sec­ond time at the helm of the eye care com­pa­ny, which makes every­thing from oph­thalmic drugs to con­tact lens­es. He took the same role in 2010 and, with­in three years, sold the com­pa­ny to what was then known as Valeant.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER